| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human CEP110/CNTRL recombinant protein (Position: T991-E2187) was used as the immunogen for the CNTRL antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
CNTRL Antibody / Centriolin / CEP110 is a anti-CNTRL Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as Western blot (WB), Flow cytometry (FACS), ELISA with listed reactivity in Human, Mouse, Rat.
Key elements and design rationale
- Target: CNTRL
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): WB, FACS, ELISA
Biological background
Centriolin contains multiple coiled-coil domains and leucine zipper motifs that mediate self-association and recruitment of other midbody proteins, including exocyst complex components (EXOC6 and EXOC8) and SNARE regulators. During mitosis, CNTRL localizes to the midbody ring structure where it anchors vesicles essential for the final abscission step separating daughter cells. Loss of CNTRL disrupts cytokinesis, leading to multinucleation and cell cycle arrest. The protein also contributes to centrosome cohesion and Golgi organization during interphase, maintaining proper microtubule anchoring and intracellular transport.
The CNTRL antibody is widely used in cell biology and cancer research to study centrosome dynamics, cytokinesis, and vesicle trafficking. In immunofluorescence microscopy, CNTRL staining reveals punctate centrosomal and midbody localization, while western blot analysis identifies a high molecular weight band of approximately 230 kilodaltons. Because defects in CNTRL function are associated with abnormal cell division and chromosomal instability, this antibody is valuable for examining mitotic control and tumorigenesis. CNTRL dysregulation has been reported in several cancers, including glioblastoma and ovarian carcinoma, where centrosome amplification and cytokinetic failure contribute to genomic instability.
Beyond its role in mitosis, CNTRL participates in cilia formation and signaling. It anchors specific vesicles involved in ciliogenesis, linking basal bodies to the Golgi apparatus. The CNTRL antibody enables detection of this dual localization pattern and supports mechanistic studies into centrosome-related diseases (centrosomopathies).
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Flow cytometry: quantify target-positive populations and signal shifts at single-cell resolution.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
